Effects of Fibrillar Aβ 1-40 on the Viability of primary Cultures of Cholinergic Neurons and the Expression of Insulin Signaling-Related Proteins

Anatomical Record

Volumn 294, Issue 2, 2011, Pages 287-294

  Du, Yi Feng ^a   Yan, Peng ^a   Guo, Shou Gang ^a   Qu, Chuan Qiang ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Basal forebrain; Cholinergic neurons; Fibrillar amyloid peptide; Insulin signal transduction pathway; Rats

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN KINASE B; TETRAZOLIUM;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL CULTURE; CELL LOSS; CELL STRUCTURE; CELL VIABILITY; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; FEMALE; FETUS; IMMUNOFLUORESCENCE; MICROSCOPE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHOLINERGIC FIBERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MODELS, ANIMAL; NEURONS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 78651461774     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21088     Document Type: Article

References (22)

1. Choi DW. 1995. Calcium: still center-stage in hypoxic-ischemic neuronal cell death. Trends Neurosci 18: 58-60.
2. Guo CN, Zhao YB, Wang YM, Wang QS, Ma AM. 2004. The effects of Aβ25-35 with different concentrations to the growth and TrkA-expression of cultured primitive rat basal forebrain cholinergic neurons. Chinese Journal of Neurology 37:278.
3. Hoyer S. 1998. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes? A challenging hypothesis. J Neural Transm 105: 415-422.
4. Hoyer S. 2000. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Cause and consequences: an update. Exp Gerontol 35: 1363-1372.
5. Hoyer S. 2002. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109: 341-360.
6. Hoyer S, Lee SK, Löffler T, Schliebs R. 2000. Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci 920: 256-258.
7. Hu J, Van Eldik LJ. 1999. Glial-derived proteins active cultured astrocytes and enhance beta amyloid-induced glial activation. Brain Res 842: 46-54.
8. Hugon J, Terro F, Esclaire F, Yardin C. 2000. Markers of apoptosis and models of programmed cell death in Alzheimer's disease. J Neural Transm Suppl 59: 125-131.
9. Kristin L, Sanderson KL, Butler L, Ingram VM. 1997. Aggregates of a β-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's disease. Brain Res 744:7-14.
10. Lehéricy S, Hirsch EC, Cervera-Piérot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y. 1993. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 330: 15-31.
11. Magrané J, Rosen KM, Smith RC, Walsh K, Gouras GK, Querfurth HW. 2005. Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 25: 10960-10969.
12. Malouf AT. 1992. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging 13: 543-551.
13. Ma XC, Sha YL, Lin KC, Nie SQ. 2002. The effect of fibrillar A beta 1-40 on membrane fluidity and permeability. Protein Pept Lett 9: 173-178.
14. Ma XC, Sha YL, Lin KC, Nie SQ. 2003. Effect of Aβ1-40 on membrane permeability and intracellular free Ca2+ of nerve cells. Chin Sci Bull 48: 10974-10978.
15. McDermott JR, Gibson AM. 1997. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res 22: 49-56.
16. Meng Y, Xu H, Wang R, Ji Z, Yu S, Zhou J, Sheng S. 2002. Impairment of signal transduction pathway on neuronal survival in brains of Alzheimer's disease. Chin J Pathol 31: 502-505.
17. Pallitto MM, Ghanta J, Heinzelman P, Kiessling LL, Murphy RM. 1999. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry 38: 3570-3578.
18. Phiel CJ, Wilson CA, Lee VM, Klein PS. 2003. GSK-3alpha regulates production of A1zheimer's disease amyloid-beta peptides. Nature 423: 435-439.
19. Schubert M, Brazil DP, Burks DJ, Kushner JA, Ye J, Flint CL, Farhang-Fallah J, Dikkes P, Warot XM, Rio C, Corfas G, White MF. 2003. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23: 7084-7092.
20. Watson D, Castaño E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly ES Jr, Esh C, Luehrs DC, Stine WB, Rowse LM, Emmerling MR, Roher AE. 2005. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Neurol Res 27: 869-881.
21. Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R. 2002. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neuorsci 22: RC221.
22. Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM. 2004. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J Neurosci 24: 11120-11126.